Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.56 CAD | -1.75% | -5.08% | +89.83% |
Apr. 25 | NurExone Biologic Announces OTCQB Listing And DTC Eligibility | MT |
Apr. 02 | NurExone Biologic Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 26.98M 36.87M |
---|---|---|---|---|---|
Net income 2024 * | -4M -5.47M | Net income 2025 * | -4M -5.47M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.55
x | P/E ratio 2025 * |
-4.55
x | Employees | 12 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.95% |
1 day | -1.75% | ||
1 week | -5.08% | ||
Current month | -3.45% | ||
1 month | -12.50% | ||
3 months | -13.85% | ||
6 months | +80.65% | ||
Current year | +89.83% |
Managers | Title | Age | Since |
---|---|---|---|
Lior Shaltiel
CEO | Chief Executive Officer | - | 21-03-31 |
Eran Ovadya
DFI | Director of Finance/CFO | - | 22-06-14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jay Richardson
BRD | Director/Board Member | 78 | 22-01-02 |
Gadi Riesenfeld
BRD | Director/Board Member | 79 | 23-07-05 |
Yoram Drucker
CHM | Chairman | 59 | 19-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 0.56 | -1.75% | 33,500 |
24-05-09 | 0.57 | -3.39% | 22,465 |
24-05-08 | 0.59 | +1.72% | 14,050 |
24-05-07 | 0.58 | -4.92% | 37,000 |
24-05-06 | 0.61 | +3.39% | 1,500 |
Delayed Quote Toronto S.E., May 10, 2024 at 03:59 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+89.83% | 26.98M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- NRX Stock